These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26027776)

  • 21. Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept.
    Fernandes BM; Pereira JM; Pereira PR; Bernardes M
    J Rheumatol; 2022 Jan; 49(1):116-117. PubMed ID: 34526392
    [No Abstract]   [Full Text] [Related]  

  • 22. [Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha].
    Brocq O; Plubel Y; Breuil V; Grisot C; Flory P; Mousnier A; Euller-Ziegler L
    Presse Med; 2002 Nov; 31(39 Pt 1):1836-9. PubMed ID: 12496713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis.
    García-Lagunar MH; Gutiérrez-Cívicos MR; García-Simón MS; Conesa-Zamora P; Jimenez-Santos E; Cano-Vivar P; García-Márquez A; Muñoz-García I; Viney AC
    Ann Pharmacother; 2017 May; 51(5):388-393. PubMed ID: 27920336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study.
    Batteux B; Devauchelle A; Boyard PL; Sejourné A; Fardellone P; Goëb V
    Joint Bone Spine; 2016 Oct; 83(5):607-9. PubMed ID: 26919803
    [No Abstract]   [Full Text] [Related]  

  • 25. TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice.
    Falgarone G; Duclos M; Boissier MC
    Joint Bone Spine; 2007 Dec; 74(6):523-6. PubMed ID: 18092377
    [No Abstract]   [Full Text] [Related]  

  • 26. Periprosthetic Joint Infection in Patients Receiving TNFα Antagonists.
    Snir N; Schwarzkopf R; Sobieraj M; Lovy AJ; Slover JD
    Bull Hosp Jt Dis (2013); 2014; 72(4):253-8. PubMed ID: 25986347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment].
    Di Gangi M; Foti R; Leonardi R; Leonetti C; Castellino P
    Reumatismo; 2007; 59(2):169-72. PubMed ID: 17603697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.
    Sakaida H; Komase Y; Takemura T
    Mod Rheumatol; 2010 Dec; 20(6):611-6. PubMed ID: 20585825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis.
    Nadarajah K; Pritchard C
    J Clin Rheumatol; 2005 Apr; 11(2):120-2. PubMed ID: 16357718
    [No Abstract]   [Full Text] [Related]  

  • 30. ANCA-positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor alpha.
    Alkhunaizi AM; Dawamneh MF
    Int J Rheum Dis; 2017 Nov; 20(11):1843-1847. PubMed ID: 26012729
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.
    Francis S; Block MJ
    Arthritis Rheum; 2010 Sep; 62(9):2826; author reply 2826-8. PubMed ID: 20556822
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumocystis jirovecii pneumonia developed in a patient with rheumatoid arthritis after 14 weeks of iguratimod add-on to treatment with methotrexate and etanercept.
    Arita Y; Taguchi H; Kobayashi M; Tono T; Ohsone Y; Okano Y
    Mod Rheumatol; 2018 Nov; 28(6):1041-1043. PubMed ID: 27180974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute ocular myositis occurring under etanercept for rheumatoid arthritis.
    Couderc M; Mathieu S; Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2014 Oct; 81(5):445-6. PubMed ID: 24746476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moraxella catarrhalis-induced septic arthritis of a prosthetic knee joint in a patient with rheumatoid arthritis treated with anakinra: comment on the article by Schiff et al.
    Leonardou A; Giali S; Daoussis D; Siambi V; Gogos H; Liossis SN
    Arthritis Rheum; 2005 Apr; 52(4):1337; author reply 1338. PubMed ID: 15818660
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.
    Curtis JR; Patkar N; Xie A; Martin C; Allison JJ; Saag M; Shatin D; Saag KG
    Arthritis Rheum; 2007 Apr; 56(4):1125-33. PubMed ID: 17393394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance.
    Yamanaka H; Hirose T; Endo Y; Sugiyama N; Fukuma Y; Morishima Y; Sugiyama N; Yoshii N; Miyasaka N; Koike T
    Mod Rheumatol; 2019 Sep; 29(5):737-746. PubMed ID: 30092161
    [No Abstract]   [Full Text] [Related]  

  • 37. Transient hyperthyroidism in a patient with rheumatoid arthritis treated by etanercept.
    Allanore Y; Brémont C; Kahan A; Menkès CJ
    Clin Exp Rheumatol; 2001; 19(3):356-7. PubMed ID: 11407100
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there a link between the use of etanercept and Henoch-Schönlein purpura? Comment on: Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept (Eur J Dermatol 2010; 20: 521-2).
    Park SJ; Kim JH; Shin JI
    Eur J Dermatol; 2011; 21(1):147. PubMed ID: 21227894
    [No Abstract]   [Full Text] [Related]  

  • 39. Iatrogenic transverse myelitis in a patient with rheumatoid arthritis.
    Sarathchandran P; Alboudi A; AlSuwaidi R; Almadani AA
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30898959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.